Antonis K.
- Country
- Greece
- Department
- Hematology - Oncology Unit, 1st Pediatric Clinic of Athens’ University (UnPOHem)
Research Overview
- Evaluation of the Efficacy, Safety, and Tolerability of Subcutaneous REGN7999 in Adults with Iron Overload Due to Non-Transfusion Dependent Beta-Thalassemia
- Asciminib in Pediatric Philadelphia-Positive Chronic Myeloid Leukemia in Chronic Phase With or Without T315I Mutation: Phase II Safety and Efficacy Study
- Phase II Evaluation of Pembrolizumab with Chemotherapy in Pediatric and Young Adult Classical Hodgkin Lymphoma with Slow Early Response
Data & Insights
Has run more than one trial at 191 of 343 partner sites.
Specializations
Pediatric Oncology
This investigator specializes in the treatment of high-risk neuroblastoma, focusing on advanced therapeutic strategies for pediatric cancer patients.
- Complex Treatment Protocols
- Metastatic Disease Management
- Neuroblastoma Research
Their work encompasses innovative approaches in treating aggressive forms of pediatric solid tumors.
Therapeutic Innovation
The investigator explores multiple treatment modalities including chemoimmunotherapy and high-dose chemotherapy approaches for advanced pediatric cancers.
- Combined Therapy Strategies
- Treatment Response Assessment
- Therapeutic Optimization
Their research involves evaluating various therapeutic combinations to improve patient outcomes.
Radiation Oncology
The investigator studies radiotherapy applications in pediatric cancer treatment, with particular focus on precise dosing strategies and targeted approaches.
- Targeted Radiation Delivery
- Post-surgical Treatment
- Dose Optimization
Their expertise includes the development of radiotherapy protocols for residual disease management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.